Gene Page:TENM1
Summary?
GeneID | 10178 |
Symbol | TENM1 |
Synonyms | ODZ1|ODZ3|TEN-M1|TNM|TNM1 |
Description | teneurin transmembrane protein 1 |
Reference | MIM:300588|HGNC:HGNC:8117|Ensembl:ENSG00000009694|HPRD:06669|Vega:OTTHUMG00000022721 |
Gene type | protein-coding |
Map location | Xq25 |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DNM:Gulsuner_2013 | Whole Exome Sequencing analysis | 155 DNMs identified by exome sequencing of quads or trios of schizophrenia individuals and their parents. |
Section I. Genetics and epigenetics annotation
DNM table
Gene | Chromosome | Position | Ref | Alt | Transcript | AA change | Mutation type | Sift | CG46 | Trait | Study |
---|---|---|---|---|---|---|---|---|---|---|---|
TENM1 | chrX | 123526073 | C | T | NM_001163278 NM_001163279 NM_014253 |
p.1839W>* p.1838W>* p.1832W>* |
nonsense nonsense nonsense |
Schizophrenia | DNM:Gulsuner_2013 |
Section II. Transcriptome annotation
General gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/TENM1_DE_GTEx.png)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
死神:胎儿(13 - 26 postconception周),ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
FAM20A | 0.84 | 0.48 |
AC079210.1 | 0.84 | 0.51 |
GRID2IP | 0.81 | 0.59 |
NEXN | 0.81 | -0.04 |
RGS16 | 0.80 | 0.17 |
CARD11 | 0.80 | -0.08 |
ATP2A3 | 0.80 | 0.38 |
RGS3 | 0.79 | 0.21 |
CCDC136 | 0.79 | 0.41 |
FAM19A4 | 0.79 | -0.17 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
CXCL14 | -0.30 | -0.68 |
SPARCL1 | -0.30 | -0.56 |
OAF | -0.29 | -0.71 |
TNFSF12 | -0.27 | -0.61 |
GRASP | -0.27 | -0.55 |
RLBP1 | -0.27 | -0.67 |
COX4I2 | -0.27 | -0.69 |
SERTAD1 | -0.27 | -0.63 |
AF347015.2 | -0.26 | -0.70 |
ITPKA | -0.26 | -0.57 |
Section III. Gene Ontology annotation
Molecular function | 去的术语 | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0008201 | heparin binding | TAS | 10341219 | |
Biological process | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0007399 | nervous system development | TAS | neurite (GO term level: 5) | 10341219 |
GO:0007165 | signal transduction | IEA | - | |
GO:0008285 | negative regulation of cell proliferation | TAS | 10556288 | |
GO:0006955 | immune response | TAS | 10556288 | |
Cellular component | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0005576 | extracellular region | TAS | 10341219 | |
GO:0016020 | membrane | IEA | - | |
GO:0016021 | integral to membrane | IEA | - |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-124/506 | 2399 | 2405 | m8 | hsa-miR-506 | UAAGGCACCCUUCUGAGUAGA |
hsa-miR-124brain | UAAGGCACGCGGUGAAUGCC | ||||
miR-149 | 1573 | 1579 | m8 | hsa-miR-149brain | UCUGGCUCCGUGUCUUCACUCC |
miR-153 | 1726 | 1732 | 1A | hsa-miR-153 | UUGCAUAGUCACAAAAGUGA |
miR-17-5p/20/93.mr/106/519.d | 2445 | 2451 | m8 | hsa-miR-17-5p | CAAAGUGCUUACAGUGCAGGUAGU |
hsa-miR-20abrain | UAAAGUGCUUAUAGUGCAGGUAG | ||||
hsa-miR-106a | AAAAGUGCUUACAGUGCAGGUAGC | ||||
hsa-miR-106bSZ | UAAAGUGCUGACAGUGCAGAU | ||||
hsa-miR-20bSZ | CAAAGUGCUCAUAGUGCAGGUAG | ||||
hsa-miR-519d | CAAAGUGCCUCCCUUUAGAGUGU | ||||
miR-186 | 1654 | 1660 | m8 | hsa-miR-186 | CAAAGAAUUCUCCUUUUGGGCUU |
miR-190 | 114 | 120 | m8 | hsa-miR-190 | UGAUAUGUUUGAUAUAUUAGGU |
miR-196 | 1668 | 1674 | 1A | hsa-miR-196a | UAGGUAGUUUCAUGUUGUUGG |
hsa-miR-196b | UAGGUAGUUUCCUGUUGUUGG | ||||
miR-200bc/429 | 212 | 218 | m8 | hsa-miR-200b | UAAUACUGCCUGGUAAUGAUGAC |
hsa-miR-200c | UAAUACUGCCGGGUAAUGAUGG | ||||
hsa-miR-429 | UAAUACUGUCUGGUAAAACCGU | ||||
miR-203.1 | 1205 | 1212 | 1A,m8 | hsa-miR-203 | UGAAAUGUUUAGGACCACUAG |
miR-23 | 133 | 139 | m8 | hsa-miR-23abrain | AUCACAUUGCCAGGGAUUUCC |
hsa-miR-23bbrain | AUCACAUUGCCAGGGAUUACC | ||||
miR-323 | 133 | 139 | 1A | hsa-miR-323brain | GCACAUUACACGGUCGACCUCU |
miR-329 | 673 | 679 | 1A | hsa-miR-329brain | AACACACCUGGUUAACCUCUUU |
miR-34/449 | 432 | 438 | 1A | hsa-miR-34abrain | UGGCAGUGUCUUAGCUGGUUGUU |
hsa-miR-34c | AGGCAGUGUAGUUAGCUGAUUGC | ||||
hsa-miR-449 | UGGCAGUGUAUUGUUAGCUGGU | ||||
hsa-miR-449b | AGGCAGUGUAUUGUUAGCUGGC | ||||
miR-34b | 123 | 129 | m8 | hsa-miR-34b | UAGGCAGUGUCAUUAGCUGAUUG |
hsa-miR-34b | UAGGCAGUGUCAUUAGCUGAUUG | ||||
hsa-miR-34b | UAGGCAGUGUCAUUAGCUGAUUG | ||||
miR-369-3p | 2427 | 2434 | 1A,m8 | hsa-miR-369-3p | AAUAAUACAUGGUUGAUCUUU |
miR-374 | 2428 | 2434 | m8 | hsa-miR-374 | UUAUAAUACAACCUGAUAAGUG |
miR-378 | 2436 | 2442 | 1A | hsa-miR-378 | CUCCUGACUCCAGGUCCUGUGU |
miR-410 | 815 | 821 | 1A | hsa-miR-410 | AAUAUAACACAGAUGGCCUGU |
miR-448 | 1725 | 1732 | 1A,m8 | hsa-miR-448 | UUGCAUAUGUAGGAUGUCCCAU |
miR-495 | 162 | 168 | m8 | hsa-miR-495brain | AAACAAACAUGGUGCACUUCUUU |
miR-496 | 95 | 101 | 1A | hsa-miR-496 | AUUACAUGGCCAAUCUC |
miR-505 | 2060 | 2066 | 1A | hsa-miR-505 | GUCAACACUUGCUGGUUUCCUC |
miR-539 | 806 | 813 | 1A,m8 | hsa-miR-539 | GGAGAAAUUAUCCUUGGUGUGU |
miR-544 | 996 | 1003 | 1A,m8 | hsa-miR-544 | AUUCUGCAUUUUUAGCAAGU |
miR-9 | 25 | 32 | 1A,m8 | hsa-miR-9SZ | UCUUUGGUUAUCUAGCUGUAUGA |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Clickhereto see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Clickhereto see the list of brain related miRNAs.